Gossamer Bio Inc. logo

Gossamer Bio Inc.

GOSS | NASDAQ
Chart Builder DCF Calculator
$11.28
+$0.55 (+5.13%)
At close: Sep 21, 2026, 4:00 PM ET
$11.49
+$0.21 (+1.86%)
Pre-market: Sep 22, 2026, 6:56 AM ET

Market Data

Market Cap
$65.57M
Enterprise Value
$51M
Beta
2.00
Average Volume
3.94M
Shares Outstanding (Diluted)
234.14M
Shares Change YoY
3.02%
Institutional Ownership
79.24%
Exchange
NASDAQ
ISIN
US38341P1021

Price Performance

Price Change 1M
-6.0%
Price Change 3M
-17.7%
Price Change 6M
-63.0%
Price Change YTD
-95.1%
Price Change 1Y
-95.5%
Price Change 3Y
-82.4%
Price Change 5Y
-98.8%
1M CAGR (ann.)
-24.8%
1Y CAGR (ann.)
-95.5%
5Y CAGR (ann.)
-57.8%
All-Time CAGR
-47.4%

Valuation

PE Ratio
-16.11
Forward PE
N/A
PEG Ratio
0.08
Forward PEG
0.01
PS Ratio
1.29
Forward PS
3.40
PB Ratio
-0.73
P/FCF Ratio
-0.42
P/Adj. FCF Ratio
-0.39
P/OCF Ratio
-0.19
EV/Sales
0.96
EV/EBIT
-0.25
EV/EBITDA
-0.25
EV/FCF
-0.31
Earnings Yield
-6.2%
FCF Yield
-235.9%
Adj. FCF Yield
-256.7%

Financial Health

Net Cash
$20.88M
Total Debt
$39.1M
Cash & Short-Term Investments
$57.03M
Total Assets
$76.87M
Current Ratio
0.53
Quick Ratio
0.53
Debt / Equity Ratio
-0.42
Debt / EBITDA
-0.19
Debt / FCF
-0.24
OCF / Debt
-4.16
Interest Coverage
-15.16
Altman Z-Score
-35.66
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
99.6%
Operating Profit Margin
-311.7%
EBITDA Margin
-384.7%
Net Profit Margin
-235.0%
FCF Margin
-305.2%
Adj. FCF Margin
-332.1%
SBC / Revenue
26.9%
SBC Impact (per share)
-8.8%

Returns

Return on Assets
-162.9%
Return on Equity
108.8%
Return on Invested Capital
670.0%
Return on Capital Employed
272.7%
Return on Tangible Assets
-162.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-33.7%
Revenue CAGR 5Y
38.8%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-26.2%
EPS CAGR 5Y
45.6%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-74.2%
FCF CAGR 5Y
5.0%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
17
EPS Growth Next 3Y
80.7%
Revenue Growth Next 3Y
48.9%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$3.47
Price Target Upside
-69.2%

Cash Flow

Operating Cash Flow
$-162.63M
Free Cash Flow
$-162.63M
Adj. Free Cash Flow
$-176.96M
FCF Per Share
-$58.93
OCF Per Share
-$58.93
OCF/S Ratio
-305.2%

Income Statement

Revenue
$53.29M
Gross Profit
$53.05M
Operating Income
$-166.09M
EBITDA
$-204.98M
Net Income
$-125.22M
EPS (Diluted)
-$0.70
Revenue / Employee
$370.04K
Profit / Employee
$-869.6K
Employees
144

© 2026 bestshares.com. All rights reserved.